Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Benitec Biopharma Ltd. ADR (BTEBY)

BTEBY RSS Feed
Add BTEBY Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Wildbilly, Blane
Search This Board:
Last Post: 9/20/2014 3:39:36 AM - Followers: 38 - Board type: Free - Posts Today: 1
Silencing Genes For Life™





 
                                                                                                                                                    
 
ddRNAi: expressed RNA interference technology
ddRNAi (DNA-directed RNAi) is a unique platform technology for silencing unwanted or disease-causing genes. In the context of therapy, ddRNAi avoids many of the drawbacks of other gene silencing technologies and produces much longer-lasting effects. Benitec Biopharma pioneered ddRNAi and was the first company to demonstrate expressed RNAi in human cells. We hold a dominant intellectual property position in RNAi, with over 40 issued global patents for the human use of ddRNAi. Learn how ddRNAi could target countless human and viral genes. Track our pipeline programs using this exciting technology. View the scope of our patents in ddRNAi. Join us in developing transformational solutions for human health.

Pipeline for ddRNAi gene silencing

Benitec Biopharma’s pipeline of in-house and partnered programs to develop therapeutics for chronic and life-threatening conditions is based on our proprietary technology, DNA-directed RNA(ddRNAi). View our out-licensed programs  

Due to its demonstrated ability to effect long-lasting gene silencing, once proven in human trials, ddRNAi technology has significant potential to treat or cure a broad range of human diseases and conditions. These include cancers, neurological diseases, infectious diseases, autoimmune diseases, genetic diseases and other afflictions that are associated with the expression of a small number of key genes.



Our in-house pipeline is summarized below,  In-house pipeline

 

. View our out-licensed programs  Out-licensed programs Successful development of therapeutic products in just one of these programs would be a major breakthrough in medical therapy.


 


 

 





 

Expressed RNAi for lasting treatment or cure

Tacere Therapeutics develops human therapeutics based on RNA interference (RNAi)  and ddRNAi gene-silencing technology from Benitec Biopharma. Using this approach, the drugs we create promise long term treatment or cure with a single dose.

We target human diseases for which there is currently no effective treatment.  Our pipeline includes drugs for Hepatitis C and Age-Related Macular Degeneration.

Tacere Therapeutics is a Benitec Biopharma company.


http://www.tacerebio.com/index.htm
 


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BTEBY
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#1099  Sticky Note Upcoming milestones and value driving events georgejjl 08/31/14 08:54:16 AM
#1024  Sticky Note Benitec Info/Due Diligence Consolidated 8-16-2014 Blane 08/16/14 03:16:25 PM
#1138   Gradalis and Strike Bio inc. georgejjl 09/20/14 03:39:33 AM
#1137   This article falls shy on what gilead has Blane 09/19/14 05:42:24 PM
#1136   Only difference is BNIKF is not sponsored and SmokeyNYY 09/19/14 04:26:41 PM
#1135   Question from a rookie. What difference does Stanski 09/19/14 04:14:36 PM
#1134   Yes just adjusting for price. Anyway the volume SmokeyNYY 09/19/14 01:05:05 AM
#1133   Benitec's competition for hepatitis C treatment georgejjl 09/18/14 08:40:53 PM
#1132   Not sure what your post means Smoke. Minding 09/18/14 02:42:02 PM
#1131   Multiply that by 5 and we are about SmokeyNYY 09/18/14 01:19:39 PM
#1130   Ten day volume: Minding 09/18/14 10:24:36 AM
#1129   BTEBY now getting more daily volume than BNIKF. SmokeyNYY 09/18/14 02:18:51 AM
#1128   Regarding Bemitec georgejjl 09/14/14 12:52:09 PM
#1127   Benitec videos georgejjl 09/11/14 07:45:02 PM
#1126   Bioshares Update Blane 09/11/14 01:37:44 AM
#1125   For sure. Blane 09/10/14 08:56:19 PM
#1124   Nice article. Wow, the possibilities. RCH68 09/10/14 08:36:46 PM
#1123   Tribetarna Article Seeking Alpha Blane 09/10/14 05:14:43 PM
#1122   Interesting article. http://www.fiercebiotech.com/story/rd-pioneer-tackles-next Blane 09/10/14 11:22:40 AM
#1121   It's obvious they know the companies, but are Blane 09/09/14 10:41:14 PM
#1120   I hope it's a lot more than 1.2b. RCH68 09/09/14 09:29:56 PM
#1119   http://www.marketwatch.com/story/rna-therapeutics-market-is-expected-to-reach-12 Blane 09/09/14 09:26:05 PM
#1118   Benitec to present at Biopharm America 2014 this Blane 09/08/14 10:01:54 PM
#1117   Not sure. But Novartis has some very Blane 09/04/14 10:10:30 AM
#1116   Any clue at what amount of buy in RCH68 09/04/14 07:36:35 AM
#1115   Seeking Alpha article from February that talks about Blane 09/04/14 01:33:14 AM
#1114   An article looking at the financial aspect of Blane 09/03/14 09:12:25 PM
#1113   I'm getting excited about the NSCLG trial. I RCH68 09/03/14 05:36:48 PM
#1112   For sure. But it's unpredictability makes it Blane 09/02/14 10:39:48 PM
#1111   and back down we go in aussie land SmokeyNYY 09/02/14 10:33:37 PM
#1110   I don't know. They could if they Blane 09/02/14 08:28:09 PM
#1109   Do y'all think Benitec will give us a RCH68 09/02/14 05:33:17 PM
#1108   Yeah, Cool is definitely an investing bi-polar, that's Blane 09/02/14 05:06:10 PM
#1107   Hahaha. He hasn't posted in a few SmokeyNYY 09/02/14 04:34:39 PM
#1106   Yes sir.. I was going to sell last RCH68 09/02/14 04:21:08 PM
#1105   Highest volume day ever for BTEBY. Lots SmokeyNYY 09/02/14 12:50:53 PM
#1104   Have you ever heard of Dr. Gero Huetter??? georgejjl 09/01/14 03:07:53 PM
#1103   Calimmune "...The dual construct employed in the present analysis georgejjl 09/01/14 02:45:45 PM
#1102   It was May 28th which is in Q2. RCH68 08/31/14 04:03:07 PM
#1101   They did not start dosing in Q1. RCH68 08/31/14 03:59:50 PM
#1100   Here is what I expect regarding the TT-034 georgejjl 08/31/14 09:12:21 AM
#1099   Upcoming milestones and value driving events georgejjl 08/31/14 08:54:16 AM
#1098   Interesting from HC Benitec is a gene therapy/RNAi RCH68 08/29/14 10:44:33 PM
#1097   That's pretty funny. Over-react much? ;-P Blane 08/29/14 10:10:55 PM
#1096   Go check out HC..A guy said the trial RCH68 08/29/14 08:37:05 PM
#1095   From DUKE georgejjl 08/29/14 06:48:27 PM
#1094   Pannobhaso's update on the most recent delay Blane 08/29/14 05:13:38 PM
#1093   Not sure, but I think they were beginning, Blane 08/29/14 05:04:26 PM
#1092   Anybody know what Pharmasset's market cap was a RCH68 08/29/14 04:42:28 PM
#1091   Think about this georgejjl 08/29/14 10:03:26 AM
#1090   Benitec Benitec has developed this new screening strategy with georgejjl 08/29/14 09:20:43 AM
#1089   Benitec with Duke and UCSD have developed a georgejjl 08/29/14 09:02:26 AM
PostSubject